• Nenhum resultado encontrado

Potential role of immunotherapy in advanced non-small-cell lung cancer

N/A
N/A
Protected

Academic year: 2021

Share "Potential role of immunotherapy in advanced non-small-cell lung cancer"

Copied!
10
0
0

Texto

Loading

Imagem

Figure 1 immunoediting mechanism.
Figure 2 Mechanism of action of immune checkpoint inhibitors.
Table 1 Efficacy and safety of immunotherapies for NSCLC

Referências

Documentos relacionados

Exosomes isolation and characterization in serum is feasible in non-small cell lung cancer patients: critical analysis of evidence and potential role in clinical practice2.

American Society of Clinical Oncology provisional clinical opinion: epidermal growth factor receptor (EGFR) Mutation testing for patients with advanced non-small-cell lung

Phase II randomized trial comparing sequential first-line everolimus and second-line sunitinib versus first-line sunitinib and second-line everolimus in patients with metastatic

Clinical model to predict survival in chemonaive patients with advanced non-small-cell lung cancer treated with third-generation chemotherapy regimens based on eastern

Long-term Results of RTOG 0236: A Phase II Trial of Stereotactic Body Radiation Therapy (SBRT) in the Treatment of Patients with Medically Inoperable Stage I Non-Small Cell

grier S, Hutson TE, et al.: Randomized phase II trial of first-line treatment with sorafenib versus interferon in patients with advanced renal cell carcinoma: Final results. Ryan

In crude and multivariate analyses, sociodemographic and medical characteristics (including breast cancer treatments) and patient-reported outcomes at baseline were not associated

Relativamente à DU esta pode ser variável em gatos com hipertiroidismo, logo quando a DU é <1.040 a suspeita de insuficiência renal aumenta, porém este valor não permite por si só